Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial
Sirima, S.B., Durier, C., Kara, L., Houard, S., Gansane, A., Loulergue, P., Bahuaud, M., Benhamouda, N., Nebié, I., Faber, B., Remarque, E., Launay, O., Ouedraogo, E., Sanou, G., Gueguen, S., Lopez PeVolume:
35
Language:
english
Journal:
Vaccine
DOI:
10.1016/j.vaccine.2017.09.027
Date:
October, 2017
File:
PDF, 2.20 MB
english, 2017